BLUE WATER LIFE SCIENCE ADVISORS LP
Q2 2023 Form 13-F

LARKSPUR, CALIFORNIA
CIK 0001789778 · CRD 306450 · SEC-registered investment adviser
$148.2M Reported Value Total

BLUE WATER LIFE SCIENCE ADVISORS, LP reports 5 total accounts under management (AUM). There are 5 discretionary accounts valued at $231,380,370, and 0 non-discretionary accounts.

Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered Discretionary Manager
Private funds (Form ADV)
6 funds · $330.0M gross asset value
Hedge Fund: $318.2M · Private Equity Fund: $11.8M
Source: Form ADV filed 2026-03-26
Reported value
$148.2M
Quarter over quarter
-9.4%
Holdings
7
Top-10 concentration
100.0%

Key People

Form ADV owners & control persons
Nathaniel Thomas Cornell
PORTFOLIO MANAGER AND MANAGING MEMBER AND CHIEF COMPLIANCE OFFICER

Filing Navigation

13F Metrics

Loading 13F Metrics

Q2 2023 13F record

Q2 2023 13F filing summary

Q2 2023 Form 13F portfolio summary
Period of report June 30, 2023
Filed August 14, 2023
Form 13F-HR
Reported value $148.2M
Positions 7
Change in reported value -2.0%
New positions 1
Exited positions 2
Position turnover 33.3%
Top-10 concentration 100.0%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q3 2026 13F
Filed Nov 13, 2026
8 $251.6M
Q2 2026 13F
Filed Aug 14, 2026
9 $158.8M
Q1 2026 13F
Filed May 14, 2026
10 $124.7M
Q4 2025 13F
Filed Feb 17, 2026
9 $159.3M
Q3 2025 13F
Filed Nov 14, 2025
7 $109.6M
Q2 2025 13F
Filed Aug 14, 2025
8 $126.3M
Q1 2025 13F
Filed May 15, 2025
7 $100.9M
Q4 2024 13F
Filed Feb 13, 2025
9 $112.9M
Q3 2024 13F
Filed Nov 14, 2024
8 $113.7M
Q2 2024 13F
Filed Aug 9, 2024
8 $102.8M
Q1 2024 13F
Filed May 15, 2024
8 $106.3M
Q4 2023 13F
Filed Feb 14, 2024
9 $114.2M
Q3 2023 13F
Filed Nov 14, 2023
7 $105.9M
Q2 2023 13F
Filed Aug 14, 2023
7 $148.2M
Q1 2023 13F
Filed May 15, 2023
8 $151.2M
Q4 2022 13F
Filed Feb 14, 2023
8 $148.9M
Q3 2022 13F
Filed Nov 14, 2022
9 $247.8M
Q2 2022 13F
Filed Aug 15, 2022
9 $184.1M
Q1 2022 13F
Filed May 18, 2022
10 $210.7M
Q4 2021 13F
Filed Feb 14, 2022
13 $326.9M

4 earlier quarters on file — choose one from the quarter menu above.

Top 7 holdings · Q2 2023

Largest Q2 2023 13F positions by reported value
# Holding Reported value % of portfolio
1 NTRA NATERA INC $42.9M 28.95%
2 AKYA AKOYA BIOSCIENCES INC $34.7M 23.43%
3 GH GUARDANT HEALTH INC $24.2M 16.34%
4 ADPT ADAPTIVE BIOTECHNOLOGIES COR $20.3M 13.72%
5 NSTG NANOSTRING TECHNOLOGIES INC $11.0M 7.45%
6 MXCT MAXCYTE INC $8.7M 5.84%
7 SONX SONENDO INC $6.3M 4.26%

Values as reported on the Q2 2023 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Performance

Loading Performance

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings